Newborn Screening for Cystic Fibrosis in New York State: In Reply

PEDIATRICS ◽  
2007 ◽  
Vol 120 (1) ◽  
pp. 241-243
Author(s):  
R. Giusti ◽  
A. Badgwell ◽  
A. D. Iglesias
PEDIATRICS ◽  
2007 ◽  
Vol 120 (1) ◽  
pp. 241-241
Author(s):  
M. Caggana ◽  
L. Helton

PEDIATRICS ◽  
1989 ◽  
Vol 83 (5) ◽  
pp. 903-905
Author(s):  
Sandra Hernandez

The ultimate objective of newborn screening for sickle cell disease should be twofold. The first essential step is the identification of the infants at risk. This has been effectively done in New York state as of 1975 through the New York State Newborn Screening Program. However, identifying these children is not enough. Second is the much more complicated task of providing comprehensive follow-up care for families whose children are affected by the disease, including the much needed psychosocial services. This area continues to be sorely neglected. The increased risk of death due to overwhelming infection in the first 3 years of life for children with sickle cell disease has been noted in the literature. When there is no specialized care, 15% to 20% do not survive. Therefore, it is essential for knowledgeable staff to make contact and begin to develop a trusting relationship as soon as possible with parents of infants born with sickle cell disease. Prophylactic penicillin and pneumococcal vaccination can reduce mortality during the early years. Family involvement with a consistent, available team of health care providers is pivotal in understanding this chronic illness and coping effectively with this extraordinary stress. Our staff is available by telephone for consultations with patients or other medical staff during clinic and emergency room visits and hospitalizations. One element that is clear in our experience at the St Luke's-Roosevelt Hospital Sickle Cell Center in New York City is that adjustment to this chronic illness is a lifelong process. One or two counseling sessions at the time of diagnosis are not sufficient to enable families to fully understand the information given or to realize the impact of having a child with a chronic illness.


2008 ◽  
Vol 42 (14) ◽  
pp. 5361-5367 ◽  
Author(s):  
Henry M. Spliethoff ◽  
Lin Tao ◽  
Shannon M. Shaver ◽  
Kenneth M. Aldous ◽  
Kenneth A. Pass ◽  
...  

2017 ◽  
Vol 20 (6) ◽  
pp. 608-613 ◽  
Author(s):  
Jennifer N Kraszewski ◽  
Denise M Kay ◽  
Colleen F Stevens ◽  
Carrie Koval ◽  
Bianca Haser ◽  
...  

2016 ◽  
Vol 18 (12) ◽  
pp. 1235-1243 ◽  
Author(s):  
Melissa P. Wasserstein ◽  
◽  
Mary Andriola ◽  
Georgianne Arnold ◽  
Alan Aron ◽  
...  

PEDIATRICS ◽  
1992 ◽  
Vol 90 (6) ◽  
pp. 1008-1009
Author(s):  
G. J. MIZEJEWSKI ◽  
K. A. PASS

To the Editor.— We recently have documented a relationship between serum α-fetoprotein (AFP) and congenital hypothyroidism (CH) in the newborn period. Previous studies in our laboratory and others had reported a relationship between elevated serum AFP and elevated thyroid-stimulating hormone (TSH)/low thyroxine T4 in newborns and infants in the first few months of life.1-4 The New York State Newborn Screening Program for CH routinely screens more than 300 000 specimens per year diagnosing 120 to 140 confirmed cases of CH annually.


Sign in / Sign up

Export Citation Format

Share Document